Early and Empirical High-Dose Cryoprecipitate for Hemorrhage After Traumatic Injury

This clinical trial examines whether early, empirical, high-dose cryoprecipitate, in addition to standard major hemorrhage protocols, would improve survival in

Related Keywords

United Kingdom ,Glasgow ,Glasgow City ,London ,City Of ,Helsinki ,Eteläuomen Läi ,Finland ,Ross Davenport ,Christopher Seymour ,Drug Administration Investigational New ,Health Technology Assessment ,United Kingdom National Institute For Health ,Queen Mary University Of London ,Group Information ,Decisio Health ,Centre For Trauma Sciences ,Blood Transfusion Service ,Consent For Emergency Research ,Barts Charity ,Care Research ,Blizard Institute ,Injury Severity Score ,Informed Consent ,Emergency Research ,Consolidated Standards ,Reporting Trials ,Glasgow Outcome Scale ,Glasgow Coma Scale ,Outcome Scale ,Abbreviated Injury Scale ,Median Injury Severity Score ,Associate Editor ,Trauma Sciences ,Queen Mary University ,Interest Disclosures ,United Kingdom National Institute ,